Figure 2. HTS identified miRNA inhibitors that have general effects on lung cancer cell survival and response to paclitaxel. Shown are Venn diagrams of the miRNA inhibitors that affect cell survival and response to paclitaxel of the three lung cancer cell lines, using thresholds of 30% (A) and 20% (B) for the magnitude of their effects on cell survival and response to paclitaxel.